PortonBio takes full advantage of the high R&D capacity and state-of-the-art facility to build a first class R&D and CDMO platform. It aims to become a reliable partner with domestic and global pharmeceuticals and biotechs.
R&D and pilot production center
Its current facility is 5000 square meters, which is located in the beautiful SuZhou Industrial Park. The facility is fully compliant with cGMP, FDA, EU-GMP and NMPA standard. We provide all services from research, process development to clinical Phase I for monoclonal antibodies and gene cell therapy biologics, which are strongly supported by analytical development and quality control.
Read more
R&D and production center
PortonBio is actively expanding its R&D and production capacity. The much larger future site for R&D and commercial production is located in Biological Medicine Research Center, Xiangcheng, Suzhou. The first phase of the plant is about 30,000 square meters and mostly serves Phase II and III clinical and commercial production for global clients and partners.
Read more